四川国为制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
18
NMPA:18
Drug Approvals
Moxifloxacin Hydrochloride Tablets
- Product Name
- 盐酸莫西沙星片
- Approval Number
- 国药准字H20183530
- Approval Date
- Oct 23, 2023
NMPA
Solifenacin Succinate Tablets
- Product Name
- 琥珀酸索利那新片
- Approval Number
- 国药准字H20183365
- Approval Date
- Apr 20, 2023
NMPA
Eldecalcitol Soft Capsules
- Product Name
- 艾地骨化醇软胶囊
- Approval Number
- 国药准字H20233063
- Approval Date
- Feb 9, 2023
NMPA
Icosapent Ethyl Soft Capsules
- Product Name
- 二十碳五烯酸乙酯软胶囊
- Approval Number
- 国药准字H20233110
- Approval Date
- Jan 31, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found